Kindstar Globalgene Technology, Inc. (SEHK:9960) entered into a equity transfer agreement to acquire 11.38% stake in Beijing Bofurui Gene Diagnostic Technology Co., Ltd. for CNY 31.9 million on June 30, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 HKD | -0.70% |
|
-0.70% | -16.07% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.07% | 172M | |
-18.17% | 8.55B | |
+86.51% | 4.63B | |
+16.31% | 2.98B | |
-3.15% | 2.65B | |
-6.18% | 1.89B | |
-53.27% | 1.81B | |
-13.14% | 1.56B | |
+23.57% | 1.27B | |
-47.38% | 1.07B |
- Stock Market
- Equities
- 9960 Stock
- News Kindstar Globalgene Technology, Inc.
- Kindstar Globalgene Technology, Inc. entered into a equity transfer agreement to acquire 11.38% stake in Beijing Bofurui Gene Diagnostic Technology Co., Ltd. for CNY 31.9 million.